Post-IPO Equity - X4 Pharmaceuticals - Dec 7, 2022 Funding Round Profile - Cointime

Bitcoin $98,386.05 +4.25%
Ethereum $3,365.29 +9.22%
BNB $623.53 +2.50%
Optimism $2.09 +25.36%
Arbitrum $0.78 +16.93%
Solana $255.70 +8.93%
Polygon $0.45 +2.30%
Cosmos $6.35 +1.62%
Avalanche $36.04 +6.92%

Bitcoin $98,386.05 +4.25%
Ethereum $3,365.29 +9.22%
BNB $623.53 +2.50%
Optimism $2.09 +25.36%
Arbitrum $0.78 +16.93%
Solana $255.70 +8.93%
Polygon $0.45 +2.30%
Cosmos $6.35 +1.62%
Avalanche $36.04 +6.92%

X4 Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 65M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Jun 30, 2022	Post-IPO Equity	$ 55M	Hercules Capital,Acorn Bioventures,etc.	Detail
Nov 16, 2017	Series A	0	Thynk Capital, LLC.	Detail
Mar 19, 2021	Post-IPO Equity	$ 55M	Abingworth,Altium Capital,etc.	Detail
Nov 16, 2017	Series B	$ 27M	Cormorant Asset Management	Detail
Dec 15, 2015	Series A	$ 37.49M	Cormorant Asset Management	Detail
Jan 1, 2014	Seed	0	SV Health Investors	Detail
Nov 17, 2017	IPO	0		Detail